Richesse Face
Richesse
Skin BoosterPolynucleotide (PN) tissue stimulator for face and neck rejuvenation
Certifications
- Richesse Face is promoted in the EU and UK as a professional medical Aesthetic product and is reported by some distributors as CE Certified within broader Richesse biostimulator ranges.
- Richesse PN products (including Face) are described by JDBIO as high Quality PN 0.2% solutions manufactured under strict quality control for medical aesthetics.
- Some marketing materials highlight CPNP/European cosmetic Product notification for related Richesse PN boosters; practitioners should verify the local regulatory classification (medical device vs. cosmetic) before use.
- Intended exclusively for professional use in compliance with local regulations governing injectable skin boosters and regenerative aesthetic treatments.
- Richesse Face is promoted in the EU and UK as a professional medical Aesthetic product and is reported by some distributors as CE Certified within broader Richesse biostimulator ranges.
- Richesse PN products (including Face) are described by JDBIO as high Quality PN 0.2% solutions manufactured under strict quality control for medical aesthetics.
- Some marketing materials highlight CPNP/European cosmetic Product notification for related Richesse PN boosters; practitioners should verify the local regulatory classification (medical device vs. cosmetic) before use.
- Intended exclusively for professional use in compliance with local regulations governing injectable skin boosters and regenerative aesthetic treatments.
Polynucleotide (PN) tissue stimulator for face and neck rejuvenation
Description
Richesse Face is a premium polynucleotide (PN) skin booster powered by high-purity salmon-derived DNA (sodium DNA 0.2%, 2 mg/ml) designed to enhance deep tissue regeneration and restore a youthful glow. Injected into the superficial to mid-dermal layers, it works from the epidermis downwards to stimulate cellular repair, strengthen the skin barrier and boost collagen and elastin synthesis. The treatment improves hydration, elasticity and skin density, helping to smooth superficial lines and wrinkles, refine enlarged pores, even skin tone and revive radiance. Richesse Face is indicated for full-face, neck, décolletage and hand rejuvenation and is intended for professional use only as a regenerative, non-volumising skin quality booster.
Bnefits
- Stimulates deep tissue regeneration with high-purity salmon-derived polynucleotides (sodium DNA 0.2%, 2 mg/ml), enhancing the skin’s self-healing capacity and reversing visible signs of ageing.
- Supports increased collagen and elastin production for improved skin bounce, firmness and tone.
- Improves moisture retention and barrier function, creating a dewy, plump and resilient complexion.
- Helps smooth the appearance of superficial lines and wrinkles and softens early to moderate signs of ageing.
- Can assist in tightening and refining enlarged pores and improving overall texture for a smoother skin surface.
- Brightens and evens skin tone, helping to reduce dullness and pigmentation for a more luminous complexion.
- Strengthens the skin’s protective barrier, contributing to improved long-term skin health and resilience.
- Provides natural-looking, subtle rejuvenation with long-lasting results when used in a series of treatments, suitable for patients seeking a non-surgical, regenerative solution.
Indications
- Full-face skin revitalisation to improve texture, hydration, firmness and radiance.
- Treatment of superficial lines and early wrinkles on the cheeks, forehead and perioral area.
- Neck rejuvenation to address crepey texture, fine lines and mild laxity.
- Décolletage rejuvenation for photo-damaged or finely wrinkled chest skin.
- Hand rejuvenation to improve skin quality, fine lines and dullness.
- Patients seeking improvement in enlarged pores, uneven tone and loss of skin bounce without adding significant bulk volume.
Composition
- Sodium DNA (Polynucleotide, PN) 0.2% (2 mg/ml) derived from salmon DNA (PDRN), as primary regenerative active.
- Hyaluronic acid (HA), reported by several distributors as combined with PN in the formulation to support hydration and dermal matrix quality (exact concentration commonly referenced around 20 mg/ml but not consistently disclosed by the manufacturer).
- Niacinamide (Vitamin B3) and peptides to support brightening, barrier function and regenerative signalling, as referenced in brand social media and distributor materials.
- Additional excipients in a buffered aqueous solution (phosphate-buffered saline, pH ~7) for injectable use (full INCI available from manufacturer on request).
Formulation
- Injectable polynucleotide (PN) tissue stimulator solution for intradermal use, derived from salmon DNA (PDRN).
- High-purity sodium DNA 0.2% (2 mg/ml) in a clear, low-viscosity aqueous solution suitable for mesotherapy-style or micro-bolus injections.
- Designed to be injected into the epidermal to dermal layers to stimulate cellular repair, collagen synthesis and barrier strengthening from within.
- Non-crosslinked, non-volumising biostimulator that focuses on skin quality rather than structural filling.
- Ready-to-use, sterile formulation supplied in prefilled syringe(s) or vials depending on distributor (commonly 2.5 ml x 1 syringe; some markets also offer 2 x 1 ml presentations).
Packaging
- Standard manufacturer presentation listed as 2.5 ml x 1 prefilled syringe of Richesse Face solution.
- Some distributors offer Richesse Face as 2 x 1 ml syringes for full-face revitalisation protocols.
- Each syringe/vial supplied sterile, typically with tamper-evident blister packaging and outer carton.
- Outer carton labelled with product name (RICHESSE Face), main active (PN / Sodium DNA), volume, batch/lot number, expiry date and manufacturer (JDBIO Co., Ltd.).
- Intended for professional clinic use only; accessories such as needles and syringes may be supplied by some wholesalers but are not universally included.
Usage
- For professional use only: Richesse Face must be administered exclusively by qualified healthcare or aesthetic practitioners trained in PN injection techniques and facial anatomy.
- Before treatment, obtain a full medical history including allergies (especially to fish/salmon-derived products), autoimmune or bleeding disorders, medications (e.g. anticoagulants) and previous aesthetic procedures; obtain informed consent.
- Cleanse the treatment area thoroughly and disinfect according to clinic protocol.
- Draw the required volume from the prefilled syringe or vial; if supplied as a syringe, attach a suitable fine-gauge needle (commonly 30G) securely to the luer-lock tip and expel air before use.
- Inject using mesotherapy-style micro-deposits, linear threading or micro-bolus techniques in the superficial to mid-dermis across the face, neck, décolletage or hands, depending on indication and practitioner preference. Avoid intravascular injection and high-risk anatomical zones.
- Typical protocol recommended by the manufacturer and multiple distributors: a series of 3–4 sessions spaced approximately 2–3 weeks apart for optimal results, with optional maintenance treatments thereafter.
- After injection, gently massage or tap the skin where appropriate to distribute the product evenly, avoiding excessive pressure or trauma.
- Post-treatment, advise patients to avoid makeup for the rest of the day, minimise sun exposure, and avoid saunas, hot baths, strenuous exercise and alcohol for 24–48 hours, following clinic-specific aftercare guidance.
- Recommend daily use of broad-spectrum sunscreen and gentle skincare to support outcomes.
- Discard any unused product from an opened syringe/vial at the end of the session; do not reuse or resterilise. Dispose of all sharps and consumables in appropriate clinical waste containers.
Contraindications
- Known hypersensitivity or allergy to polynucleotides, fish/salmon-derived ingredients or any component of the product.
- Active skin infection, inflammation, eczema, dermatitis or unhealed wounds in the treatment area.
- History of severe allergic reactions or anaphylaxis to injectable aesthetic products.
- Uncontrolled systemic disease, severe coagulation disorders or current use of strong anticoagulant therapy, unless carefully evaluated and cleared by the treating physician.
- Pregnancy and breastfeeding, due to limited safety data for PN-based aesthetic treatments.
- Known tendency to hypertrophic or keloid scarring in areas planned for treatment when using needle-based procedures.
- Use in patients under 18 years of age is not recommended.
Adverse Effects
- Common, usually transient injection-site reactions such as redness, mild swelling, tenderness, warmth and occasional bruising.
- Pinpoint bleeding, especially when using mesotherapy or microneedling-assisted delivery techniques.
- Temporary feeling of tightness or sensitivity in treated areas.
- Short-term dryness or mild flaking as the skin renews in the days following treatment.
- Rare localised hypersensitivity or inflammatory reactions (persistent redness, oedema, induration or itching); treatment should be discontinued and medical evaluation sought if such reactions occur.
- As with all injectable procedures, improper technique or inadequate asepsis can increase the risk of infection or, rarely, vascular compromise; clinics should have appropriate emergency protocols in place.
Storage Conditions
- Store in accordance with manufacturer guidance in a cool, dry place away from direct sunlight and heat sources; many PN injectables are stored at controlled room temperature and must not be frozen (users should check the specific pack labelling).
- Keep the syringe/vial in its original blister and outer carton until use to maintain sterility and protect from light.
- Do not use after the expiry date printed on the packaging.
- Do not use if the packaging is damaged, previously opened or if the solution shows discoloration or visible particles.
- After opening, use immediately for a single treatment session and discard any remaining product.
- Store out of the sight and reach of children and untrained persons.
Duration
Manufacturer and distributor descriptions emphasise long-lasting results following a course of 3\u20134 Richesse Face sessions; in clinical practice, PN skin boosters are generally considered to provide visible improvement for several months, with many protocols recommending maintenance treatments roughly every 6\u201312 months depending on individual skin condition and response.
Onset
Noticeable improvements in hydration and radiance can often be seen after the first treatment, with progressive changes in skin texture, elasticity, tone and fine lines developing over the following weeks as tissue regeneration and collagen synthesis occur.
| Price | Link |
|---|---|
| £45.00 | https://aestheticswarehouse.co.uk/product/richesse-face/ |













